Skip to main content

Published locations for Metastatic CRC: Better tumor response and disease control with FTD/TPI vs regorafenib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Metastatic CRC: Better tumor response and disease control with FTD/TPI vs regorafenib

User login

  • Reset your password
  • /content/metastatic-crc-better-tumor-response-and-disease-control-ftd/tpi-vs-regorafenib
  • /hematology-oncology/article/246295/gi-oncology/metastatic-crc-better-tumor-response-and-disease